Health Populi

MARCH 11, 2021

[Note: I may be biased as a University of Michigan graduate of both the School of Public Health and Rackham School of Graduate Studies in Economics]. health care, patient assistance programs, Medicare Advantage plans, and the bundling of proven high-value preventive services into the Affordable Care Act.

Health Policy 245

Health Policy Medicare Pharmaceuticals Life Science 245

Health Populi

JUNE 24, 2021

The economic and healthcare system impacts of this were explored in the Post-Covid Healthcare Landscape , delivered by Fitch Solutions’ Jamie Davies and Beau Noafshar, leaders in the Pharmaceuticals, Healthcare, and Medical Devices groups. spends on NASA.

BioTech 270

BioTech Pharmaceuticals Public Health Telehealth 270

Health Populi

OCTOBER 28, 2019

patients’ negative views of the pharmaceutical industry in this study was the opioid epidemic. Over one-half of Americans blame pharmaceutical companies as most responsible for the opioid crisis, followed by physicians, whom 39% of health consumers blame, and patients, whom 38% of people blame. Exacerbating U.S.

Pharmaceuticals 136

Pharmaceuticals Medical Billing Medicare Mental health 136

Health Populi

MAY 8, 2019

In 2018, we saw more incentives to inspire adherence to prescription drug regimens, particularly in Medicare Part D along with increasing focus by pharmacists and providers. Just under 9% of patients across all three health plan types had over $500 in OOP costs in 2018. A cost of $125 or more yields abandonment of at least 50%.

Medicare 149

Medicare BioTech Pharmaceuticals Mental health 149

Health Populi

JUNE 18, 2020

The authors, Dr. Naci and Dr. Kesselheim, are affiliated with the London School of Economics and Brigham and Women’s Hospital in Boston, note that 1% of medicines dispensed under Medicare Part D and Medicaid accounted for nearly $1 in $3 of drug spending in each program in 2015. bn to $32.8 bn to $9.9 bn for Medicaid.

BioTech 191

BioTech Medicare Life Science Telehealth 191

Health Populi

MARCH 6, 2019

is prescription drug prices — that they’re too high, that the Federal government should negotiate to lower costs for Medicare enrollees, and that out-of-pocket costs for drugs should be limited. That would be profits made by pharmaceutical companies, cited by 80% of respondents. consumers were asked.

Pharmaceuticals 140

Pharmaceuticals Life Science Medicare BioTech 140

Health Populi

AUGUST 16, 2021

There is one health care public policy issue that unites U.S. voters across political party: that is the consumer-facing costs of prescription drugs.

Pharmaceuticals 323

Pharmaceuticals Telehealth BioTech Mental health 323